More Articles Back to Article
Genexine of S. Korea initiates coronavirus vaccine trial in humans
South Korean biotech firm Genexine is one of the companies developing a COVID-19 vaccine and has seen its company shares increase 14% last weekend on the news. The company announced it has enrolled the first of about 40 participants for its early-stage human trial to test its COVID-19 vaccine candidate. Reuters (6/19)
Read full article now.
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!